Dyslipidemias in critically ill patients with sepsis and septic shock

• Conditions: A41.9; Sepsis, unspecified

• Registration Number: DRKS00015315
• Lead Sponsor: KH Universitätsklinikum Graz

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2019-01-14
• Study Completion: 2022-02-28
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 78

Inclusion Criteria

Age >= 18 years, Sepsis or septic shock as defined by sepsis-3-criteria (suspected infection and rise in SOFA-score >=2), Admission to the IC

Exclusion Criteria

Palliative care, comfort terminal care, AIDS, pregnancy, Age > 100 years

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
There will be two primary outcome variables:<br>1. prevalence of dyslipidemia in sepsis and septic shock<br>2. 28-day mortality

Secondary Outcome Measures

Name	Time	Method
1. correlation of dyslipidemia with 28-day mortality<br>2. correlation of dyslipidemia with SOFA score<br>3. correlation of dyslipidemia with inflammatory parameters<br>4. correlation of dyslipidemia with enteral/parenteral nutrition<br>5. correlation of dyslipidemia with medication (i.e. propofol)